Texas Fertility Center Research Advances Ovarian Reserve Testing & Progesterone Delivery

Texas Fertility Center presented studies at the ASRM conference showing vaginal gels and rings can replace painful progesterone injections, with 84% of patients preferring the new methods. Their research also highlights AMH testing as a superior predictor of IVF success over estrogen levels.

---

Key Takeaways

Progesterone Gel and Vaginal Ring: Safer, More Comfortable Alternatives to Injections

Texas Fertility Center’s study confirmed that vaginal progesterone gels and rings are as effective as injections but preferred by 84% of patients for being less painful and messy. This shift improves patient compliance and reduces treatment stress.

AMH Testing Predicts IVF Success Better Than Estrogen

New data from TFC shows anti-Müllerian hormone (AMH) testing is a more reliable indicator of IVF outcomes than estrogen levels. Combining AMH with FSH, age, and follicle counts helps tailor personalized treatment plans.

Comprehensive Ovarian Reserve Testing Enhances IVF Treatment Planning

Ovarian reserve assessments using Day 3 FSH, AMH, and ultrasound evaluations provide a 360° view of fertility potential. This multi-faceted approach allows physicians to optimize stimulation protocols for better pregnancy rates.

Age and Ovarian Follicle Count Influence IVF Outcomes

A patient’s age, ovarian size, and early-cycle follicle development are critical factors in determining IVF success. These metrics help Texas Fertility Center customize treatment timelines and drug dosages for maximum efficacy.

Texas Fertility Center Leads in Fertility Research and Innovation

Through partnerships with institutions like Teva Pharmaceuticals, TFC pioneers advancements like progesterone delivery systems and AMH-based diagnostics. Their ASRM-presented work sets new standards in reproductive medicine.

---

Source: Read full article